Breaking News

Bayer Drops Out in the Race for Schiff

November 20, 2012

According to published reports, Bayer AG has ceased its pursuit of Schiff Nutrition International Inc., ending speculation that the deal was poised to become the industry’s most expensive acquisition.

Late last month German drugmaker Bayer announced its intent to buy Schiff for $34 a share, or about $1.1 billion including net debt, according to Bloomberg. The situation grew interesting when Reckitt Benckiser Group Plc made a surprise offer of $42 a share, or about $1.4 billion.

In a filing with the U.S. Securities and Exchange Commission Bayer said that a competitive bidding process “would result in a price outside Bayer’s set financial criteria.”

blog comments powered by Disqus
  • Reading Tea Leaves—Or Just Making Tea

    Reading Tea Leaves—Or Just Making Tea

    Steve Mister, Council for Responsible Nutrition||July 1, 2015
    Industry must begin to have candid, introspective conversations about the future regulation of dietary supplements.

  • Nutrition is Key, But Taste is King

    Nutrition is Key, But Taste is King

    Lisa Olivo, Associate Editor||July 1, 2015
    When it comes to eating healthy, flavor is a vital concern for consumers.

  • Formulating Healthy Beverages

    Formulating Healthy Beverages

    Pete Maletto, President & Senior Scientist, PTM Food Consulting||July 1, 2015
    Consumers are actively looking for hydration with added benefits while also reducing calories and eliminating sugar and artificial ingredients.